Source: MassDevice

Amniox Medical: Amniox Medical touts no re-herniation in Clarix microdiscectomy trial

Amniox Medical today released results from a clinical study of its Clarix cryopreserved amniotic membrane in lumbar microdiscectomy surgeries, touting freedom from re-herniation for 2-years. Results from the trial were published in the May 2017 issue of Clinical Spine Surgery, the Atlanta-based company said. In the 80-person study, researchers compared the use of the Clarix 100 [...]The post Amniox Medical touts no re-herniation in Clarix microdiscectomy trial appeared first on MassDevice.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Amy Tseng's photo - President & CEO of Amniox Medical

President & CEO

Amy Tseng

CEO Approval Rating

86/100

Read more